RetinalGenix Technologies Inc.
Company Information
Industry
Surgical & Medical Instruments & Apparatus
SIC Code
3841
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation
DE
Business Address
1450 NORTH MCDOWELL BOULEVARD, PETALUMA, CA, 94954
Mailing Address
1450 NORTH MCDOWELL BOULEVARD, PETALUMA, CA, 94954
Phone
415-578-9583
Fiscal Year End
1231
EIN
823936890
Financial Overview
FY2025
-$1.41M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | April 15, 2026 | View on SEC |
| 8-K Current report of material events | March 26, 2026 | View on SEC |
| 10-Q Quarterly financial report | November 14, 2025 | View on SEC |
| 10-Q/A Quarterly report amendment | August 20, 2025 | View on SEC |
| 10-Q Quarterly financial report | August 19, 2025 | View on SEC |
| 10-Q Quarterly financial report | May 15, 2025 | View on SEC |
Annual Reports
10-K
April 15, 2026
- Developing a portable 'RetinalCam' for home-based eye health monitoring.
- Creating a proprietary genetic testing oral swab for retinal disease risk assessment.
Related Companies
Companies in the same industry (SIC: 3841)
FAMILY OFFICE OF AMERICA, INC.
FOFA
Surgical & Medical Instruments & Apparatus
HeartBeam, Inc.
BEAT
Surgical & Medical Instruments & Apparatus
MIMEDX GROUP, INC.
MDXG
Surgical & Medical Instruments & Apparatus
DEXCOM INC
DXCM
Surgical & Medical Instruments & Apparatus
Nu-Med Plus, Inc.
NUMD
Surgical & Medical Instruments & Apparatus
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.